R BIO CO LTD has a total of 21 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Republic of Korea, United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GENOVO INC, BRESAGEN INC and Hope Biosciences LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Japan | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Kang Sung Keun | 17 |
#2 | Ra Jeong Chan | 16 |
#3 | Lee Jin Hwa | 8 |
#4 | Lee Mi Sook | 8 |
#5 | Kwon Soon Ae | 8 |
#6 | Kim Sung-Min | 7 |
#7 | Kim Eun Young | 4 |
#8 | Park Hyeong Geun | 3 |
#9 | Ra Jung Chan | 3 |
#10 | Lee Hang Young | 3 |
Publication | Filing date | Title |
---|---|---|
KR102233568B1 | Method for Improved Cell Viability of Mesenchymal Stem Cells Infected Oncolytic-Virus | |
KR20190142266A | Method for Improved Cell Viability of Mesenchymal Stem Cells Infected Oncolytic-Virus | |
KR20190134522A | Method for Culturing Mesenchymal Stem Cells Using Gamma Irradiated Serum | |
WO2016068596A1 | Medium composition for culturing stem cells | |
KR20160079390A | Composition of Media for Culturing Stem Cell | |
KR20160050412A | Composition of Media for Culturing Stem Cell | |
US2015118194A1 | Method and composition for preventing stem cell disruption and aggregation |